Related Experiment Video
Updated: Jan 18, 2026

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
Published on: April 4, 2025
Biomarker for renal scarring screening in children with vesicoureteral reflux: a systematic review
Utari Mudhia Arisa Putri1, Putu Angga Risky Raharja1, Gerhard Reinaldi Situmorang1
1Urology Department, Cipto Mangunkusumo Hospital/Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Insights
Urinary biomarkers, especially NGAL, show promise for detecting kidney scarring in children with vesicoureteral reflux (VUR), offering a non-invasive alternative to radiation-heavy imaging. Further research is needed for clinical use.
Area of Science:
- Pediatric Urology
- Nephrology
- Biomarker Discovery
Background:
- Vesicoureteral reflux (VUR) is a common pediatric condition leading to urinary tract infections (UTIs) and potential kidney damage.
- Renal scarring from VUR can cause long-term issues like hypertension and chronic kidney disease (CKD).
- Traditional DMSA scans for renal scarring involve radiation and high costs, necessitating alternative diagnostic methods.
Purpose of the Study:
- To systematically review the diagnostic accuracy of blood and urine biomarkers for detecting renal scarring in children with VUR.
- To compare the effectiveness of various biomarkers against established imaging techniques.
Main Methods:
- A systematic review following PRISMA 2020 guidelines was conducted.
- Searches were performed on PubMed, ScienceDirect, and Cochrane databases for relevant studies.
- Diagnostic accuracy (sensitivity, specificity) and risk of bias (QUADAS-2) were assessed for included studies.
Main Results:
- Nine studies were included, evaluating biomarkers like NGAL, CRP, CXCL8/IL-8, LL-37, and IL-6.
- Urinary NGAL demonstrated the highest diagnostic performance, with sensitivity of 72%-84% and specificity of 60%-81%.
- Other biomarkers showed moderate accuracy but were less reliable than NGAL for detecting renal scarring.
Conclusions:
- Urinary biomarkers, particularly NGAL, offer a promising non-invasive approach for identifying VUR-associated renal scarring in children.
- While NGAL shows significant potential, further validation and standardization are required for routine clinical application.
Introduction:
Vesicoureteral reflux (VUR) is a prevalent pediatric urological condition that increases children's risk of urinary tract infections (UTIs) and renal damage. Renal scarring linked to VUR can lead to long-term complications, including hypertension and chronic kidney disease (CKD). Although traditional imaging techniques, such as dimercaptosuccinic acid (DMSA) scans, are regarded as the gold standard for identifying renal scarring, they come with risks of radiation exposure and high costs. This review investigates the diagnostic accuracy of blood and urine biomarkers as alternative methods for detecting renal scarring in VUR.
Methods:
This systematic review adhered to the PRISMA 2020 guidelines. We conducted a comprehensive search across three databases-PubMed, ScienceDirect, and Cochrane-for studies on biomarkers associated with renal scarring in children with VUR. The included studies were evaluated for diagnostic accuracy (sensitivity and specificity) and assessed for risk of bias using the QUADAS-2 framework.
Results:
Nine studies met the eligibility criteria and were included in the qualitative synthesis. Biomarkers such as NGAL, CRP, CXCL8/IL-8, LL-37, and IL-6 were evaluated. Among these, urinary NGAL demonstrated the best diagnostic performance, with sensitivity ranging from 72%-84% and specificity between 60% and 81%. Other biomarkers exhibited moderate accuracy, although they were less reliable than NGAL. Overall, biomarkers present a promising non-invasive alternative to traditional imaging for detecting renal scarring in children with VUR.
Conclusion:
Urinary biomarkers, particularly NGAL, hold potential for detecting VUR and renal scarring in children, providing a non-invasive alternative to traditional imaging methods. However, additional validation and standardization are necessary before these biomarkers can be routinely applied in clinical practice.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies II: Ultrasonography
Imaging Studies VII: Vascular Imaging

